Medical Devices

Recommended Steps to Decide the Regulatory Path for a Modified PMA Device

Step 1. Identify the modification and reason for it.
Step 2. Conduct a risk analysis.
Step 3. Define testing that will assess the impact of the modification on safety and effectiveness.
Step 4. Choose the regulatory pathway from the options below, see reference A below flowchart for additional
information regarding regulatory pathway choice. Multiple branches from Step 4 follow:

New clinical and new preclinical, lead to new original PMA. New clinical and potentially some new preclinical, lead to panel-track supplement. Preclinical and potentially limited confirmatory clinical, lead to 180-day supplement. Preclinical only, lead to real-time supplement. Manufacturing change affecting safety and effectiveness, lead to 30-day / 135-day supplement. Manufacturing site change supplement. Change or changes that enhance the safety of the device, lead to special supplement changes being effected. Change or changes that do not affect safety and effectiveness, lead to annual report.

Page Last Updated: 05/22/2015
Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English